logo

Biotechnology & Drugs News

Share

AstraZeneca Presents Results From Positive Phase 3 TULIP 2 Trial For Anifrolumab

Sandoz Presents Interim Analysis From COMPACT Study

Novartis Announces Detailed Results From Phase III PREVENT Trial

Beximco Pharma FY Net Sales Up 28.8% To £212.7 Mln

Eco Animal Health Says H1 Trading Results To Be Below Last Year

Sandoz Agrees To Acquire Aspen's Japanese Operations And Associated Assets

>